Safety pharmacology of acute MDMA administration in healthy subjects. - Wikidata - wikimedia - TriplyDB

Safety pharmacology of acute MDMA administration in healthy subjects.

Safety pharmacology of acute MDMA administration in healthy subjects.

http://www.wikidata.org/entity/Q38819567

about

A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects.Key interindividual determinants in MDMA pharmacodynamics.Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects.Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter.Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice.MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor.(±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA.Progress and promise for the MDMA drug development program.No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA.Oxytocin receptor gene variations and socio-emotional effects of MDMA: A pooled analysis of controlled studies in healthy subjects.Serotonin concentration enhancers at clinically relevant doses reduce [11C]AZ10419369 binding to the 5-HT1B receptors in the nonhuman primate brain.Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study

P2860

Q33843524-C9E84BA9-8FDC-4C76-B7E8-FDA2D299B1E9 Q47206849-2035241A-8B4F-410D-8846-58DD440D1691 Q47318737-EF2E2E62-88D6-40AC-BDCD-7C63D1D09D8F Q47551565-F1528D10-D2D7-4679-87CE-8DD3D8037C9D Q47662199-10967AD4-3E6D-4A90-B011-D1837747F97E Q47770844-55E3084C-3556-4778-BF26-EF7697692D63 Q47777762-DB1C4E8D-B9CE-485C-9765-C931DB85AB71 Q47963200-0DA2720F-563E-499A-A564-5C459DEBDA17 Q48190285-35985D4C-C8FE-485E-8692-F185276AC2A4 Q55264971-8F1D47EB-2353-42B2-AAE5-CF95B62E4659 Q55711478-FCF7EDBA-B017-44AA-82A2-F9A65A33036F Q57309250-8932D488-3BE0-45B2-B2CF-0F02E41D327D Q58757402-8162EE41-95EB-4AB9-872B-F1362E32E79F

P2860

Safety pharmacology of acute MDMA administration in healthy subjects.

http://www.wikidata.org/entity/Q38819567

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Safety pharmacology of acute MDMA administration in healthy subjects.

@en

type

label

Safety pharmacology of acute MDMA administration in healthy subjects.

@en

prefLabel

Safety pharmacology of acute MDMA administration in healthy subjects.

@en

P1433

Q38819567-579B9103-B034-406F-AD69-1C9B86D5BC8E

P1476

Q38819567-70538D4B-9F0C-49E7-9865-3EDC7BB88C15

P2093

Q38819567-90559E7A-D5D4-40B8-BBE4-213167A51A5D

P2860

Q38819567-0555D467-E52B-4714-A67C-A0B55445598B

Q38819567-068D7914-770C-40FE-9AFF-EB70295F3C5A

Q38819567-08645DF6-157B-4525-82E1-F16BC86127E7

Q38819567-08F6E4FC-84E0-4C4A-A0A8-2296C2927E7D

Q38819567-0938027D-0ABA-4260-9F9C-E8386FA5839E

Q38819567-0C672FB7-D0DC-46C8-A87C-236906A7D3D5

Q38819567-0F502EAA-07E5-408D-9DF0-F360EF1AA315

Q38819567-116F0742-C5BE-4B0D-9A0E-587113DE77C7

Q38819567-15AC66CD-1393-4288-AB22-74127494F43B

Q38819567-15FB201B-25CD-4288-8F4F-08FE06229D55

P304

Q38819567-0AFA586E-E4BD-457F-B801-35B4CBD27234

P31

Q38819567-A77CF8F6-12E7-498B-842E-76F58529F4D2

P356

Q38819567-43D51072-C711-461B-9CB4-1602FBC56946

P407

Q38819567-62F56184-95AE-494C-A536-25425D7CA6B0

P433

Q38819567-1EF5454F-88CF-4C44-89CA-D401EF6D5D99

P478

Q38819567-67CD007D-B270-47C8-944B-8C62A80A5A30

P50

Q38819567-27F6B19F-2AE6-4D35-9BD9-9C45760261D9

P577

Q38819567-F26323B1-ACAE-451F-A365-88E59DF620B3

P698

Q38819567-77826037-A694-4E26-8C6A-5DE5DC32BD6C

P356

0269881117691569

P1433

Journal of Psychopharmacology

P1476

Safety pharmacology of acute MDMA administration in healthy subjects

@en

P2093

Matthias E Liechti

http://www.w3.org/2001/XMLSchema#string

P2860

The Potential Dangers of Using MDMA for Psychotherapy

The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others

Neuroimaging in moderate MDMA use: A systematic review

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP

The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans

Pharmacological characterization of designer cathinones in vitro

Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study

Clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT)

P304

576-588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0269881117691569

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28443695

http://www.w3.org/2001/XMLSchema#string